Amazon launches a $5 subscription for prescription drugs

Amazon is launching RxPass in the US, a new drug subscription exclusive to Prime members that charges users a $5 monthly fee to ship eligible prescription medications to their doorstep. Announced on Tuesday in a press release, the Amazon RxPass subscription program provides generic medications to treat over 80 common health conditions, including high blood pressure, hair loss, anxiety, and acid reflux.

The $5 charge includes the cost of delivery and is added to Prime customers’ existing monthly subscription fee. The RxPass fee is a flat rate and doesn’t increase even if users require multiple prescriptions each month. Medications can be delivered on either a monthly or quarterly basis depending on the prescription requirements. Conditions covered by the service also include allergies, diabetes (excluding insulin), and anemia. Amazon says that more than 150 million Americans already take one or more of the medications available through RxPass. A full list of generic medications covered by the RxPass subscription can be found on the Amazon pharmacy website.

Customers enrolled in government programs like Medicare and Medicaid are not eligible for RxPass

Amazon has launched several healthcare services in recent years. The company closed down its original Amazon Care telehealth program (launched in 2019) in November last year in favor of its newer Amazon Clinic telehealth service. RxPass subscriptions dispense from Amazon Pharmacy — an affordable online pharmacy exclusive to Prime members that launched in 2020.

The RxPass subscription service is available today in most US states. Amazon has not announced if it will expand the list of medications or any plans to extend the service outside of the US. Customers who are enrolled in Medicare, Medicaid, or any other government healthcare program are not eligible for RxPass but can still use government insurance to fill prescriptions at Amazon Pharmacy.

For all the latest Technology News Click Here 

Read original article here

Denial of responsibility! TechAI is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.